Predictors of implantable cardioverter defibrillator shocks during the first year

Journal of Cardiovascular Nursing

Volumn 24, Issue 1, 2009, Pages 21-28

  Dougherty, Cynthia M ^a   Hunziker, Jim ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Heart failure; ICD; Logistic regression; Predictors; Shocks; Sudden cardiac arrest

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; CARDIOVERSION; DEFIBRILLATOR; EQUIPMENT; FEMALE; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NURSING METHODOLOGY RESEARCH; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS; SUDDEN DEATH; SURVIVOR; UNITED STATES;

AGED; ATTITUDE TO HEALTH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTHWESTERN UNITED STATES; NURSING METHODOLOGY RESEARCH; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURVIVORS;

EID: 64049116882     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/01.JCN.0000317473.42801.a8     Document Type: Article

References (39)

1. Germano JJ, Reynolds M, Essebag V, et al. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006; 97:1255-1261.
2. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. JAMA. 2006;295:165-171.
3. Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmetrics versus implantable defibrillators trial. Circulation. 2002;105:589-594.
4. Ahmad M, Bloomstein L, Roelke M, et al. Patients' attitudes toward implanted defibrillator shocks. PACE. 2000;23:934-938.
5. Carroll DL, Hamilton GA. Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. Heart Lung. 2005;34:169-178.
6. Winkle RA, Mead RH, Ruder MA, et al. Long term outcomes with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol. 1989;13:1353-1361.
7. Bremner SM, McCauley KM, Axtell KA. A follow-up study of patients with implantable cardioverter defibrillators. J Cardiovasc Nurs. 1993;7(3):40-51.
8. Tebbenjohanns J, Schumacher B, Jung W, et al. Predictors of outcome in patients with implantable transvenous car-dioverter defibrillators. Am Heart J. 1994;127:1086-1089.
9. Gradaus R, Block M, Brachmann J, et al. Mortality, morbidity, and complications in 3344 patients with ICDS: results from the German ICD Registry EURID. PACE. 2003;26:1511-1518.
10. Lampert R, Joska T, Burg MM, et al. Emotion and physical precipitants of ventricular arrhythmias. Circulation. 2002;106:1800.
11. Lampert R, Jain D, Burg MM, et al. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter- defibrillators. Circulation. 2000;101:158-164.
12. Menon V, Steinberg JS, Akiyama T, et al. Implantable cardioverter defibrillator discharge rates in patients with unexplained syncope, structural heart disease, and inducible ventricular tachycardia at electrophysiologic study. Clin Cardiol. 2000;23:195-200.
13. Hreybe H, Bedi M, Ezzeddine R, et al. Indications for internal cardioverter defibrillator implantation predict time to first shock and the modulating effect of β blockers. Am Heart J. 2005;150:1064.e1-1064. e5.
14. Hreybe H, Ezzeddine R, Bedi M, et al. Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J. 2006;151:852-856.
15. Srivathsan K, Scott LR, Altemose GT. T wave oversensing and inappropriate shocks: a case report. Europace. 2008; 10:552-555.
16. Whang W, Albert CM, Sears SF, et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 2005;45:1090-1095.
17. Sanchez JM, Greenberg SL, Chen J, et al. Smokers are at markedly increased risk of appropriate defibrillator shocks in a primary prevention population. Heart Rhythm. 2006; 3:443-449.
18. Verma A, Kilicaslan F, Martin DO, et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart. 2006;92:190-195.
19. Desai A, Burke M, Hong T, et al. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchro-nization therapy. J Cardiovasc Electrophysiol. 2006;17: 486-490.
20. Nanthakumar K, Dorian P, Paquette M, et al. Is inappropriate implantable defibrillator shock therapy predictable? J Inter Card Electrophysiol. 2003;8:215-220.
21. Pacifico A, Ferilic LL, Cedillo-Salazar FR, et al. Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 1999;34: 204-210.
22. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages non-sudden death: the AVID trial. Circulation. 2001;103:2066-2071.
23. Credner SC, Klingenheben T, Mauss O, et al. Electrical storm in patients with transvenous implantable cardioverter defibrillators. J Am Coll Cardiol. 1998;32: 1909-1915.
24. Dougherty CM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of the internal cardioverter defibrillator. Heart Lung. 1995;24:281-291.
25. Dunbar SB, Warner CD, Purcell JA. Internal cardioverter defibrillator device discharge: experiences of patients and family members. Heart Lung. 1993;22:494-501.
26. Luderitz B, Jung W, Deister A, Manz M. Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am Heart J. 1994;127:1179-1184.
27. Sears SF, Conti JB. Understanding implantable cardio-verter shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003;26:107-111.
28. Burgess E, Quigley J, Moran G, et al. Predictors of psychological adjustment in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1997; 20:1790-1795.
29. Fricchoine GL, Olson LS, Vlay SC. Psychiatric syndromes in patients with automatic internal cardioverter defibrillator: anxiety, psychological dependence, abuse, and withdrawal. Am Heart J. 1989;117:1411-1414.
30. Hamner M, Hunt N, Gee J, et al. PSTD and automatic implantable cardioverter defibrillators. Psychosomatics. 1999;40:82-85.
31. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/ NASPE 2002 guideline update for implantation of cardiac pacemakers and anti-arrhythmia devices: summary article. A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2002;106:2145-2161.
32. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD). Study design and methods. Am Heart J. 2000;138:1-9.
33. Katzman R, Brown T, Fuld P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734-739.
34. Speilberger C, Gorsuch R, Lushene R. Manual for the State-Trait Anxiety Inventory (Self-evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists; 1970.
35. Radloff LS. The CES-D scale: a self-report of depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401.
36. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125:2309-2321.
37. Hreybe H, Saba S. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2007;30:385-389.
38. Rankovic V, Karha J, Passman R, et al. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2002;89:1072-1076.
39. Dunbar SB, Kimble LP, Jenkins LS, et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999;9:163-168.